Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial.
Tsujita M, Kosugi T, Goto N, Futamura K, Nishihira M, Okada M, Hiramitsu T, Narumi S, Uchida K, Takeda A, Morozumi K, Maruyama S, Watarai Y. Tsujita M, et al. Among authors: nishihira m. Nephrol Dial Transplant. 2019 Aug 1;34(8):1409-1416. doi: 10.1093/ndt/gfy365. Nephrol Dial Transplant. 2019. PMID: 30561729 Free PMC article. Clinical Trial.
Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study.
Hiramitsu T, Tomosugi T, Futamura K, Okada M, Nishihira M, Goto N, Ichimori T, Narumi S, Kobayashi T, Uchida K, Watarai Y. Hiramitsu T, et al. Among authors: nishihira m. Int Immunopharmacol. 2021 Feb;91:107038. doi: 10.1016/j.intimp.2020.107038. Epub 2020 Dec 31. Int Immunopharmacol. 2021. PMID: 33388731
Everolimus-based Immunosuppression Possibly Suppresses Mean Fluorescence Intensity Values of De Novo Donor-specific Antibodies After Primary Kidney Transplantation.
Narumi S, Watarai Y, Goto N, Hiramitsu T, Tsujita M, Okada M, Futamura K, Tomosugi T, Nishihira M, Sakamoto S, Kobayashi T. Narumi S, et al. Among authors: nishihira m. Transplant Proc. 2019 Jun;51(5):1378-1381. doi: 10.1016/j.transproceed.2019.03.019. Epub 2019 May 2. Transplant Proc. 2019. PMID: 31056252 Clinical Trial.
Study of Glomerulopathy in Donors after Kidney Transplantation.
Murata M, Takeda A, Ootsuka Y, Shinjo H, Ito C, Watanabe Y, Washino M, Nakano Y, Tomosugi T, Futamura K, Okada M, Hiramitsu T, Goto N, Ichimori T, Narumi S, Watarai Y, Nishihira M, Morozumi K. Murata M, et al. Among authors: nishihira m. Nephron. 2020;144 Suppl 1:86-90. doi: 10.1159/000512137. Epub 2020 Nov 30. Nephron. 2020. PMID: 33254170
Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2 × 2 factorial, open-label, randomized clinical trial.
Obi Y, Ichimaru N, Sakaguchi Y, Iwadoh K, Ishii D, Sakai K, Iwami D, Harada H, Sumida K, Sekine A, Masutani K, Akutsu N, Inoue T, Nishihira M, Yoneda T, Ito S, Araki M, Kaimori JY, Yoshida K, Satoh S, Ubara Y, Isaka Y, Yoshida K, Tsubakihara Y, Takahara S, Hamano T; CANDLE-KIT Trial Investigators. Obi Y, et al. Among authors: nishihira m. Transpl Int. 2021 Jul;34(7):1212-1225. doi: 10.1111/tri.13885. Epub 2021 Jun 15. Transpl Int. 2021. PMID: 33884674 Free article. Clinical Trial.
47 results